Companies: 10,795·Total market cap: $144.5T
Akerna Corp.

Akerna Corp.

KERNNASDAQHealthcare
$0.31
+$0.08(+36.94%)
Market Cap$162320
P/E Ratio
52W High$20.4
52W Low$0.25
Overview

Akerna Corp.(KERN)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

kern · 股价预测 · 2 位分析师(近3月)· FMP · 更新于 2024年4月25日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Hold

2 位分析师

共识

评级分布

Strong Buy
0
Buy
0
Hold
2
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 0.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $6.27

Akerna Corp.(KERN)的分析师共识为 Hold,基于过去 3 个月内 2 位华尔街分析师的评级。KERN 的 12 个月平均目标价为 $0.00,相对当前价 $6.27 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$5.965.00%

1-day model range: $5.84–$6.07. Peak: $6.07 (-5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

36%57%7%
5Buy
8Neutral
1Sell
RSI (14)54.5Neutral
MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · KERN · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$5.30BUY
MA 10$6.09BUY
MA 20$6.12BUY
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $KERN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$5.61BUY
EMA 10$5.84BUY
EMA 20$6.34SELL
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $KERN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2023-06-02
Maintains
NeutralNeutral
HC Wainwright & Co.2023-06-01
Maintains
NeutralNeutral
HC Wainwright & Co.2023-03-24
Maintains
NeutralNeutral
HC Wainwright & Co.2023-03-23
Maintains
NeutralNeutral
HC Wainwright & Co.2022-08-25
Downgrade ↓
BuyNeutral
Alliance Global Partners2022-05-11
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2022-05-11
Maintains
BuyBuy
HC Wainwright & Co.2022-02-25
Maintains
BuyBuy
HC Wainwright & Co.2021-11-10
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Akerna Corp. (KERN) stock. Of the recent 9 rating actions, 0 were upgrades and 2 were downgrades. 2 analysts currently cover KERN.

分析师推荐趋势

Buy ratings101
Hold ratings02↑ +2
Sell ratings00

KERN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$20M

↑ 95.4% YoY

Revenue Next Year

$11M

↓ 47.2% YoY

EPS This Year

$-12.27

EPS Next Year

$-4.78

↓ 61.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast KERN EPS of $-12.27 for the current fiscal year, based on estimates from 0 analysts. The KERN revenue forecast is $20M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

KERN 股价预测由两类独立数据源支撑:来自 2 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。KERN 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Hold。

KERN 的短期预测(明日)为 $5.96(-5.00%)。

Akerna Corp. 在 NASDAQ 上市,代码 KERN。KERN 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 0% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

KERN 预测 · 8 个问题

根据 2 位华尔街分析师,KERN 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $6.27,隐含约 +0.0% 的上行空间。

KERN 目标价KERN 分析师目标价KERN 12个月目标价目标价 KERN

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.